Fresenius reported EUR2.7B in Gross Profit on Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Akzo Nobel AKZA:NA EUR 978M 55M
Alcon AG ALC:SW USD 1.17B 83M
AstraZeneca AZN:LN USD 8.86B 3M
Bayer BAYN:GR EUR 7.03B 105M
Davita Healthcare Partners DVA:US USD 863.14M 46.83M
Essilor EI:FP EUR 7.61B 808M
Fresenius FRE:GR EUR 2.7B 27M
Fresenius Medical Care FME:GR EUR 1.36B 12.59M
Fresenius Medical Care FMS:US EUR 1.36B 12.54M
Getinge GETIB:SS SEK 3.38B 231M
Givaudan GIVN:VX CHF 1.46B 84M
GlaxoSmithKline GSK:LN GBP 5.2B 244M
GN Store Nord GN:DC DKK 2.36B 125M
Hikma Pharmaceutical HIK:LN USD 623M 62M
Merck MRK:GR EUR 3.66B 200M
Novartis NOVN:VX USD 9.18B 151M
Philips PHIA:NA EUR 2.22B 491M
Roche Holding ROG:VX 22.73B 924M
Smith & Nephew PLC SN/:LN 1.83B 49M
William Demant Holding WDH:DC DKK 7.08B 13M